AIG
KURA icon

American International Group’s Kura Oncology KURA Stock Holding History

American International Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-34,775
Closed -$742K – 1445
2024
Q1 		$742K Sell
34,775
-299
-0.9% -$5.81K ﹤0.01% 1456
2023
Q4 		$504K Sell
35,074
-142
-0.4% -$1.4K ﹤0.01% 1656
2023
Q3 		$321K Buy
35,216
+3,847
+12% +$39.1K ﹤0.01% 1857
2023
Q2 		$332K Sell
31,369
-2
-0% -$24 ﹤0.01% 1890
2023
Q1 		$384K Buy
31,371
+625
+2% +$7.8K ﹤0.01% 1753
2022
Q4 		$382K Buy
30,746
+624
+2% +$9.07K ﹤0.01% 1750
2022
Q3 		$411K Buy
30,122
+425
+1% +$6.55K ﹤0.01% 1694
2022
Q2 		$544K Sell
29,697
-1,851
-6% -$26.6K ﹤0.01% 1546
2022
Q1 		$507K Sell
31,548
-2,221
-7% -$32.1K ﹤0.01% 1714
2021
Q4 		$473K Sell
33,769
-1,010
-3% -$16.4K ﹤0.01% 1848
2021
Q3 		$651K Sell
34,779
-827
-2% -$15.6K ﹤0.01% 1683
2021
Q2 		$742 Sell
35,606
-876
-2% -$21.7K ﹤0.01% 1687
2021
Q1 		$1.03K Buy
36,482
+723
+2% +$22.9K ﹤0.01% 1441
2020
Q4 		$1.17K Buy
35,759
+4,039
+13% +$142K ﹤0.01% 1305
2020
Q3 		$972K Sell
31,720
-721
-2% -$15.9K ﹤0.01% 1260
2020
Q2 		$529K Buy
32,441
+12,126
+60% +$175K ﹤0.01% 1563
2020
Q1 		$202K Sell
20,315
-1,174
-5% -$13.4K ﹤0.01% 1896
2019
Q4 		$295K Sell
21,489
-181
-0.8% -$2.68K ﹤0.01% 1990
2019
Q3 		$329K Buy
21,670
+3,242
+18% +$57.7K ﹤0.01% 1882
2019
Q2 		$363K Buy
18,428
+386
+2% +$6.41K ﹤0.01% 1886
2019
Q1 		$299K Sell
18,042
-584
-3% -$9K ﹤0.01% 1989
2018
Q4 		$262K Sell
18,626
-146
-0.8% -$1.93K ﹤0.01% 2032
2018
Q3 		$329K Buy
18,772
+2,583
+16% +$49.5K ﹤0.01% 2118
2018
Q2 		$295K Buy
16,189
+2,435
+18% +$41.2K ﹤0.01% 2144
2018
Q1 		$258K Buy
13,754
+180
+1% +$3.5K ﹤0.01% 2132
2017
Q4 		$208K Buy
13,574
+4,012
+42% +$59.1K ﹤0.01% 2298
2017
Q3 		$143K Buy
9,562
+716
+8% +$6.72K ﹤0.01% 2467
2017
Q2 		$82K Buy
+8,846
New +$80.5K ﹤0.01% 2837

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

American International Group's KURA Position: Q2 2024 in Review

American International Group sold out of Kura Oncology (KURA) in Q2 2024, closing a stake of 34,775 shares — an estimated $742K sold.

American International Group first reported a position in KURA in Q2 2017 and held it in 28 quarters. The position peaked at $972K in Q3 2020. 174 funds tracked by Wall St. Rank hold KURA as of Q2 2024.

  • American International Group reported no remaining Kura Oncology position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 34,775 Kura Oncology shares in Q2 2024, an estimated $742K.
  • American International Group first reported a position in Kura Oncology in Q2 2017 and held it in 28 quarters.
  • American International Group's Kura Oncology position peaked at $972K in Q3 2020.
  • 174 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.